S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 16.24 SEK 1.75%
Market Cap: 795.9m SEK

Wall Street
Price Targets

SYNACT Price Targets Summary
SynAct Pharma AB

Wall Street analysts forecast SYNACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYNACT is 21.42 SEK with a low forecast of 21.21 SEK and a high forecast of 22.05 SEK.

Lowest
Price Target
21.21 SEK
31% Upside
Average
Price Target
21.42 SEK
32% Upside
Highest
Price Target
22.05 SEK
36% Upside
SynAct Pharma AB Competitors:
Price Targets
XGN
Exagen Inc
13% Upside
TNG
Transgene SA
100% Upside
OPK
OPKO Health Inc
148% Upside
FYB
Formycon AG
114% Upside
1801
Innovent Biologics Inc
19% Downside
ZEAL
Zealand Pharma A/S
151% Upside
688520
Sinocelltech Group Ltd
3% Downside
300122
Chongqing Zhifei Biological Products Co Ltd
45% Upside

Revenue
Forecast

Revenue Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SYNACT's stock price target?
Price Target
21.42 SEK

According to Wall Street analysts, the average 1-year price target for SYNACT is 21.42 SEK with a low forecast of 21.21 SEK and a high forecast of 22.05 SEK.

Back to Top